LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Stanbio Expands International Distribution

By Labmedica staff writers
Posted on 14 Mar 2002
In a move to expand the distribution of its products, Stanbio Laboratory (Boerne, TX, USA) has agreed for BDS International Diagnostics Gmbh (Schwetzingen, Germany) to serve as the export sales office of Stanbio in Eastern and Western Europe, the Middle East, and the Indian subcontinent. BDS' services will include supporting and managing existing distributors and selecting and training additional distributors.

Stanbio has been producing and marketing clinical diagnostic reagents and test kits since 1960. The company's in vitro diagnostic products include clinical chemistry, serology, pregnancy, urinalysis, occult blood, microbiology, hematology, blood-grouping products, and clinical instruments. Stanbio now supplies liquid-stable and dry-powder clinical reagents as well as innovative dry-chemistry systems.

"Our product offerings will be highly attractive to the European markets, and in BDS we have a partner who shares our philosophy of quality and service,” said William R. Pippin, president of Stanbio.




Related Links:
Stanbio
BDS

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
HPV Test
Allplex HPV28 Detection
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit

Latest Industry News

New NHS Partnership Expands Access to Epigenetic CNS Tumor Classifiers
14 Mar 2002  |   Industry

Fujirebio Expands Access to Automated Blood-Based Neurology Testing in Canada
14 Mar 2002  |   Industry

Natera ctDNA Test to Support Response Monitoring in Solid Tumor Trial
14 Mar 2002  |   Industry